» Authors » Jan Gryczynski

Jan Gryczynski

Explore the profile of Jan Gryczynski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 1442
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchell S, Gryczynski J, Worley D, Asche S, Truitt A, Rindal D
Implement Res Pract . 2025 Feb; 6:26334895251319810. PMID: 39931509
Background: De-implementing non-effective or even harmful practices in healthcare is sometimes necessary, as has been the case with opioid prescribing in dentistry over the past decade. One approach to practice...
2.
Terplan M, OGrady K, Monico L, Schwartz R, Gryczynski J, Fishman M, et al.
Subst Use Addctn J . 2024 Sep; 46(1):72-77. PMID: 39297332
Background: We assess adverse events (AEs) following medication initiation for adolescents and young adults with opioid use disorder (OUD). Methods: This is a secondary analysis of a clinical trial of...
3.
Nordeck C, Kelly S, Schwartz R, Mitchell S, Welsh C, OGrady K, et al.
Addict Sci Clin Pract . 2024 Apr; 19(1):33. PMID: 38678216
Background: Individuals with substance use disorders (SUDs) frequently use acute hospital services. The Navigation Services to Avoid Rehospitalization (NavSTAR) trial found that a patient navigation intervention for hospitalized patients with...
4.
Monico L, Fletcher J, Ross T, Schwartz R, Fishman M, Gryczynski J, et al.
J Subst Use Addict Treat . 2024 Mar; 162:209334. PMID: 38531508
Background: The opioid epidemic in the United States has not spared youth or young adults, as evidenced by a six-fold increase in opioid use disorder (OUD) diagnoses in the last...
5.
Nordeck C, Sharma A, Terplan M, Dusek K, Gilliams E, Gryczynski J
J Psychiatr Brain Sci . 2024 Mar; 8(6). PMID: 38456042
Background: Despite the effectiveness and growing availability of treatment for opioid use disorder (OUD) with buprenorphine, many people with OUD do not access treatment services. This article describes the rationale,...
6.
Ware O, Hussong A, Frey J, Daughters S, Cloeren M, Gryczynski J, et al.
J Occup Environ Med . 2023 Dec; 66(3):e87-e92. PMID: 38151983
Objective: The aim of the study is to examine trends of employer/employee assistance program referred admissions to outpatient substance use disorder (SUD) treatment in the United States. Methods: The publicly...
7.
Hochstatter K, Nordeck C, Mitchell S, Schwartz R, Welsh C, Gryczynski J
Prev Med Rep . 2023 Dec; 36:102494. PMID: 38116282
Polysubstance use is becoming increasingly common and presents several harms. This study aimed to examine the association of comorbid cocaine, alcohol (binge drinking), and sedative use with mortality among hospitalized...
8.
Burruss-Cousins K, Mitchell S, Gryczynski J, Whitter M, Fuller D, Ibrahim A, et al.
J Subst Use Addict Treat . 2023 Dec; 157:209265. PMID: 38103832
Introduction: People seeking treatment at opioid treatment programs (OTPs) can face admission delays. Interim methadone (IM) treatment, an effective approach to expedite admissions when programs lack sufficient counseling staff, has...
9.
Mitchell M, Mitchell S, Brooks J, Akinwolere O, Dusek K, OGrady K, et al.
Subst Use Misuse . 2023 Dec; 59(3):329-335. PMID: 38063201
Vaping, including vaping cannabis, is increasing among adolescents. In this longitudinal study, we examined the relationship between vaping cannabis and frequency of cannabis use and related problems over 6 months...
10.
Fuller D, Gryczynski J, Schwartz R, Halsted C, Mitchell S, Whitter M
J Subst Use Addict Treat . 2023 Dec; 158:209214. PMID: 38042301
Introduction: In the United States, methadone treatment may only be provided through opioid treatment programs (OTPs), which operate under a complex system of federal and state regulations. During the pandemic,...